title: Resolution of ocular involvement with systemic eculizumab therapy in atypical hemolytic-uremic syndrome.
authors.forename: R
authors.initials: R
authors.lastname: David
authors.forename: S
authors.initials: S
authors.lastname: Hochberg-Klein
authors.forename: R
authors.initials: R
authors.lastname: Amer
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000150:complications*; D006801:Humans; D012163:Retinal Detachment / Q000188:drug therapy*; D016896:Treatment Outcome; D014792:Visual Acuity; D055815:Young Adult
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab